Fibroblasts long regarded as structural cells also serve as active modulators of local immunity. Single-cell analyses revealed a subset of stromal cells that express antigen-presentation machinery, reshaping how tissues sense and respond to danger. Evidence from Einat Elyada at the Weizmann Institute of Science and Aviv Regev at the Broad Institute of MIT and Harvard shows that in human pancreatic tumors a distinct population of cancer-associated fibroblasts expresses MHC class II and antigen-processing genes, indicating direct engagement with CD4 T cells.
Antigen processing and presentation mechanisms
Antigen-presenting fibroblasts acquire, process, and load peptides onto MHC class II molecules much like classical antigen-presenting cells, though often with lower expression of co-stimulatory molecules. This profile enables them to present environmental, self, or tumor-derived peptides to CD4+ T cells, delivering signals that can be activating, regulatory, or tolerogenic depending on context. In tissues with persistent antigen exposure, such as mucosae or chronically inflamed sites, fibroblast presentation tends toward immune modulation rather than full activation, shaping local T cell phenotypes and promoting tissue-specific memory or tolerance.
Relevance, causes and consequences in health and disease
The presence of antigen-presenting fibroblasts is relevant to cancer immunity, autoimmunity, infection, and tissue repair. In tumors, antigen-presenting fibroblasts can either present tumor antigens to support anti-tumor CD4+ responses or contribute to immune suppression by inducing regulatory T cell programs; both outcomes influence prognosis and responses to immunotherapy. In autoimmune conditions, stromal antigen presentation may sustain autoreactive T cells within affected tissues, perpetuating local damage. Causes for conversion to an antigen-presenting state include inflammatory cytokines such as interferon-gamma and local cues from damaged tissue or altered extracellular matrix composition.
Human and cultural dimensions arise where tissue-specific immunity intersects with environmental exposure. Mucosal fibroblasts in communities with differing microbiomes may present distinct microbial antigens, modulating vaccine responsiveness and susceptibility to infection across populations. Environmental pollutants and habitat changes that alter tissue inflammation can shift fibroblast behavior, with downstream effects on public health in affected territories.
Understanding antigen-presenting fibroblasts opens translational avenues: targeting stromal presentation pathways could refine immunotherapies, reduce autoimmunity, or enhance mucosal vaccine efficacy. Careful study of tissue context and intercellular signals is essential to harness or restrain this nonclassical antigen presentation for clinical benefit.